.
Oncology (Pathology Clinical Pharmacology Methods of Examination and Interpretation of Data, Symptomatology and Pharmacotherapy)
Study Course Description
Course Description Statuss:Approved
Course Description Version:2.00
Study Course Accepted:26.01.2023 11:14:36
| Study Course Information | |||||||||
| Course Code: | ISK_054 | LQF level: | Level 7 | ||||||
| Credit Points: | 2.00 | ECTS: | 3.00 | ||||||
| Branch of Science: | Clinical Medicine | Target Audience: | Clinical Pharmacy | ||||||
| Study Course Supervisor | |||||||||
| Course Supervisor: | Dace Baltiņa | ||||||||
| Study Course Implementer | |||||||||
| Structural Unit: | Department of Internal Diseases | ||||||||
| The Head of Structural Unit: | |||||||||
| Contacts: | Riga, 2 Hipokrata Street, isk rsu[pnkts]lv, +371 67042338 | ||||||||
| Study Course Planning | |||||||||
| Full-Time - Semester No.1 | |||||||||
| Lectures (count) | 4 | Lecture Length (academic hours) | 2 | Total Contact Hours of Lectures | 8 | ||||
| Classes (count) | 4 | Class Length (academic hours) | 4 | Total Contact Hours of Classes | 16 | ||||
| Total Contact Hours | 24 | ||||||||
| Study course description | |||||||||
| Preliminary Knowledge: | Basic human anatomy, physiology and pathology, medical biochemistry, pharmacology. | ||||||||
| Objective: | To provide students with knowledge in clinical areas – pathophysiology of diseases, clinical manifestations of oncological diseases, evaluation of examinations, basic methods of treatment and pharmacotherapy options for oncological diseases. The study module comprises an integrated learning cycle in which the student is gradually introduced to the pathological physiology of a group of diseases, clinical pharmacology, clinical manifestations, examination possibilities, interpretation of examination data, principles and types of treatment and pharmacotherapy possibilities. | ||||||||
| Topic Layout (Full-Time) | |||||||||
| No. | Topic | Type of Implementation | Number | Venue | |||||
| 1 | Epidemiology of tumours, contributing and risk factors, heredity, statistics. Tumour biology, metastasis | Lectures | 1.00 | E-Studies platform | |||||
| Classes | 1.00 | clinical base | |||||||
| 2 | Tumour classification, morphology, prognosis and predictive factors, the most common tumours, important identification nuances (lung, prostate, breast, colorectal, skin cancer, stomach cancer, gynaecological and urological tumours) | Lectures | 1.00 | E-Studies platform | |||||
| Classes | 1.00 | clinical base | |||||||
| 3 | Principles of tumour therapy (surgery, radiation, systemic pharmacotherapy – groups of medicines, indications, contraindications, possible complications and follow-up) | Lectures | 1.00 | E-Studies platform | |||||
| Classes | 1.00 | clinical base | |||||||
| 4 | Palliative and symptomatic care, interacting with an oncology patient | Lectures | 1.00 | E-Studies platform | |||||
| Classes | 1.00 | clinical base | |||||||
| Assessment | |||||||||
| Unaided Work: | The student independently studies the literature offered in the study programme, summarises the obtained information. Prepares a clinical pharmacist’s assessment of pharmacotherapy for an oncology patient. | ||||||||
| Assessment Criteria: | Active participation in practical classes; written assignments completed in high quality and submitted on time, quality of oral answers Exam: understanding of the principles of diagnosis and treatment of oncological diseases, including clinical case analysis, is tested. | ||||||||
| Final Examination (Full-Time): | Exam | ||||||||
| Final Examination (Part-Time): | |||||||||
| Learning Outcomes | |||||||||
| Knowledge: | As a result of successfully completing the course, the student will have knowledge of the following: • basic principles of carcinogenesis, genetics, tumour biology and epidemiology; • principles of tumour classification; • the most common clinical manifestations and complications of oncological diseases; • principles of cancer patient care and drug treatment; • pharmacotherapy options for oncological diseases. | ||||||||
| Skills: | The student will be able: • to inform patients about known cancer risk factors and screening options; • to assess the care and drug treatment of an oncology patient; • to assess and interpret results of oncological examinations; • to assess drug treatment for oncological diseases. | ||||||||
| Competencies: | The student will be able: • in collaboration with the medical practitioners, to determine a pharmacotherapy plan for an individual patient with an oncological disease; • to assess the advantages and disadvantages of pharmacotherapy methods in relation to the patient’s examination data; • to monitor the progress of pharmacotherapy, predict side effects and plan the prevention thereof, and provide the necessary information to other medical specialists. | ||||||||
| Bibliography | |||||||||
| No. | Reference | ||||||||
| Required Reading | |||||||||
| 1 | Lekciju un nodarbību materiāli. | ||||||||
| 2 | Oncology. An Evidence-Based Approach//Chang AE et al, Springer, 2006. (akceptējams izdevums) | ||||||||
| Additional Reading | |||||||||
| 1 | Lejniece S. Klīniskā hematoloģija. Nacionālais Medicīnas Apgāds, 2020 | ||||||||
| 2 | Oxford Handbook of Clinical Haematology. 4th ed., Oxford University Press, 2015 | ||||||||
| Other Information Sources | |||||||||
| 1 | The Merck Manual, Internets | ||||||||
| 2 | http://www.merck.com/mrkshared/manual/home.jsp | ||||||||
